|
Volumn 424, Issue 6946, 2003, Pages 251-
|
Looking into the safety of AAV vectors [2]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
RETROVIRUS VECTOR;
VIRUS VECTOR;
BONE MARROW CELL;
CANCER RISK;
CELL GROWTH;
CELL PROLIFERATION;
CELL STIMULATION;
COMBINED IMMUNODEFICIENCY;
DNA INTEGRATION;
DNA STRAND BREAKAGE;
DNA VECTOR;
GENE ACTIVATION;
GENE INSERTION;
HUMAN;
IMMUNOCOMPETENT CELL;
LETTER;
LEUKEMOGENESIS;
NONHUMAN;
ONCOGENE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STEM CELL;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
VIRUS DNA CELL DNA INTERACTION;
VIRUS RECOMBINANT;
ADENO ASSOCIATED VIRUS;
ANIMAL;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENE VECTOR;
GENETICS;
LEUKEMIA;
MOUSE;
NOTE;
PATHOGENICITY;
RETROVIRUS;
SAFETY;
INSERTION SEQUENCES;
UNIDENTIFIED RETROVIRUS;
ANIMALS;
DEPENDOVIRUS;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
LEUKEMIA;
MICE;
MUTAGENESIS, INSERTIONAL;
RETROVIRIDAE;
RISK ASSESSMENT;
SAFETY;
SEVERE COMBINED IMMUNODEFICIENCY;
VIRUS INTEGRATION;
|
EID: 0041806502
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/424251b Document Type: Letter |
Times cited : (61)
|
References (0)
|